Safety event description: a consumer experienced consumer stating she experienced blurry vision, dry eye, eye pain, lens became hard, red eyes, corneal abrasion, discomfort made nose constantly run and sound sick and tearing.Additional information received with medical record states that the consumer visited doctor and underwent eye examination in which consumer¿s lid margin, anterior chamber, iris, and lens were normal for both eyes.Conjunctiva and cornea were normal for left eye.But in right eye the consumer got diagnosed with central recurrent corneal erosion.The consumer was prescribed with moxifloxacin ophthalmic solution 0.5% with a frequency of every hour while awake, carboxy methyl cellulose sodium eye drops with a frequency of every night at bedtime and systane complete eye drops with a frequency of once in a day in the morning.The consumer was suggested to schedule a follow-up visit.The consumer visits another doctor as a follow-up visit.The consumer again underwent eye examination in which lid margin, anterior chamber, iris, conjunctiva, and lens were normal for both eyes.The diagnostic drops used were fluorescein sodium and benoxinate hydrochloride corneal examination showed abnormal tear breakup time, abnormal tbut (tear break up time) 3 seconds, lasik flap (laser-assisted in situ keratomileusis), positive punctate epithelial erosions and diagnosed with vitreous syneresis in both eyes.The consumer was advised discontinued moxifloxacin prescribed with preservative free artificial tears with a frequency of four times a day and increased dose of omega supplements.The consumer was recommended to apply warm compress to lids once in a day and to increase hydration, sleep hygiene and computer strain with decreased blink rate.The consumer was suggested to follow-up in six weeks.The current status of consumer¿s condition was resolved at the time of report.Additional information has been requested but not yet received.
|